Walk into a Neko Health clinic, stand inside a scanning pod for roughly 10 to 15 minutes, and you’ll walk out with a data portrait of your body that most annual physicals couldn’t generate in a month. That’s the pitch from the Stockholm-born startup co-founded by Spotify billionaire Daniel Ek — and now that pitch has crossed the Atlantic. As covered by TechCrunch, Neko Health has officially launched in the United States, bringing its flagship scanning experience to American consumers for the first time. The question everyone is actually asking: is a $499 out-of-pocket scan worth it — or is this just premium wellness theater?
The timing is notable. Health tech and AI-powered diagnostics are drawing serious venture attention, and consumer appetite for proactive health monitoring is outpacing what traditional healthcare systems can deliver. Neko is betting that the gap between “feeling fine” and “having actual data” is wide enough to sustain a subscription-style preventive health business.
What the Scanner Actually Does
Neko’s hardware is not a gimmick. The pod uses more than 300 sensors to collect data across a wide range of biomarkers — including heart metrics, skin assessments, blood pressure readings, and body composition measurements. The scan is non-invasive and remarkably fast for the volume of data it generates. Results are delivered digitally, paired with a physician review so patients aren’t left decoding raw numbers alone.
According to a Business Insider review of the experience, the scan is designed to feel fast, convenient, and genuinely cool — closer to an Apple Store appointment than a hospital visit. The $499 price point covers the full session, but insurance won’t touch it. That’s a deliberate design choice: Neko is positioning itself outside the reimbursement-driven healthcare system, targeting consumers who are willing to self-fund their own longitudinal health data. The experience is polished enough that it reads less like a medical appointment and more like a product launch you happen to be inside of.
The Out-of-Pocket Problem and the Bigger Picture
Here’s the tension at the center of Neko’s U.S. expansion. The scan is impressive. The data is real. But $499 per visit, with no insurance coverage, means Neko’s addressable market is essentially self-selecting for affluence. As a separate Business Insider analysis noted, Neko sits within a broader wave of health-tech devices and services that are genuinely innovative but priced in ways that widen rather than close health equity gaps. Consumers who need preventive screening most are often least positioned to pay out of pocket for it.
That caveat doesn’t make the technology less interesting — it makes the business model the more complicated story. Neko clearly isn’t trying to replace emergency medicine or chronic disease management. It’s carving out a lane in the longevity and wellness market, where consumers are already spending heavily on wearables, supplements, and continuous glucose monitors. Ek built Spotify by making music feel personal and effortless; the goal here appears to be doing the same for your health data. Whether the U.S. market rewards that vision at $499 a session — and whether Neko can eventually scale down costs enough to reach a wider audience — will define whether this is a lasting platform or an expensive novelty for the quantified-self crowd. The investment climate for health-adjacent tech remains competitive, which means Neko will face pressure to prove retention and outcomes, not just a slick first-scan experience.
